European Crohn´s and Colitis Organisation - ECCO - Published ECCO Guidelines
European Crohn's and Colitis Organisation (ECCO) 2016 Congress
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
Cureus | The Impact of Inflammatory Bowel Disease on Mortality and Other Outcomes of Hospitalized Patients With Diabetic Ketoacidosis: An Observational Study of the United States National Inpatient Sample | Article
Frontiers | Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions
ECCO Congress | efcca.org
European Crohn´s and Colitis Organisation - ECCO - Published ECCO Guidelines
11th Congress ECCO: European Crohn's and Colitis Organisation - Inflammatory Bowel Diseases
ECCO 2016: Professor Stefan Schreiber (Kiel, Germany) discusses some of the issues in managing Crohn's disease. - Medical Update Online
Cureus | Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review | Article
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease | NEJM
Life | Free Full-Text | Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
European Crohn's and Colitis Organisation (ECCO) 2016 Congress
ECCO IBD by OCEAiN Organisation, Congress, Emotion, Association, iNnovation GmbH
Current and emerging therapeutic targets for IBD | Nature Reviews Gastroenterology & Hepatology
WINTER
ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update
ECCO-EFCCA Patient Guidelines on Crohn's Disease (CD)
The IBD Management Puzzle: Do We Have All the Pieces? - European Medical Journal
12th Congress of ECCO – Inflammatory Bowel Diseases - USGE - Ulster Society of Gastroenterology